Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains

J Immunol. 2002 Feb 1;168(3):1172-80. doi: 10.4049/jimmunol.168.3.1172.

Abstract

We investigated interactions between CD4+ T cells and dendritic cells (DC) necessary for presentation of exogenous Ag by DC to CD8+ T cells. CD4+ T cells responding to their cognate Ag presented by MHC class II molecules of DC were necessary for induction of CD8+ T cell responses to MHC class I-associated Ag, but their ability to do so depended on the manner in which class II-peptide complexes were formed. DC derived from short-term mouse bone marrow culture efficiently took up Ag encapsulated in IgG FcR-targeted liposomes and stimulated CD4+ T cell responses to Ag-derived peptides associated with class II molecules. This CD4+ T cell-DC interaction resulted in expression by the DC of complexes of class I molecules and peptides from the Ag delivered in liposomes and permitted expression of the activation marker CD69 and cytotoxic responses by naive CD8+ T cells. However, while free peptides in solution loaded onto DC class II molecules could stimulate IL-2 production by CD4+ T cells as efficiently as peptides derived from endocytosed Ag, they could not stimulate induction of cytotoxic responses by CD8+ T cells to Ag delivered in liposomes into the same DC. Signals requiring class II molecules loaded with endocytosed Ag, but not free peptide, were inhibited by methyl-beta-cyclodextrin, which depletes cell membrane cholesterol. CD4+ T cell signals thus require class II molecules in cholesterol-rich domains of DC for induction of CD8+ T cell responses to exogenous Ag by inducing DC to process this Ag for class I presentation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 2
  • ATP-Binding Cassette Transporters / metabolism
  • Animals
  • Antigen Presentation* / drug effects
  • CD4-Positive T-Lymphocytes / drug effects
  • CD4-Positive T-Lymphocytes / immunology
  • CD4-Positive T-Lymphocytes / metabolism*
  • CD8-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes / metabolism
  • Cells, Cultured
  • Cholesterol / immunology
  • Cholesterol / metabolism*
  • Cyclodextrins / pharmacology
  • Cysteine Endopeptidases / metabolism
  • Cytoplasm / immunology
  • Cytoplasm / metabolism
  • Dendritic Cells / drug effects
  • Dendritic Cells / immunology*
  • Dendritic Cells / metabolism*
  • Egg Proteins / biosynthesis
  • Egg Proteins / immunology
  • Endocytosis / drug effects
  • Endocytosis / immunology
  • H-2 Antigens / biosynthesis
  • H-2 Antigens / metabolism*
  • Histocompatibility Antigens Class II / immunology
  • Histocompatibility Antigens Class II / metabolism*
  • Immunosuppressive Agents / pharmacology
  • Lymphocyte Activation / drug effects
  • Membrane Lipids / antagonists & inhibitors
  • Membrane Lipids / metabolism
  • Membrane Microdomains / drug effects
  • Membrane Microdomains / immunology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred CBA
  • Mice, Transgenic
  • Multienzyme Complexes / metabolism
  • Ovalbumin / biosynthesis
  • Ovalbumin / immunology
  • Peptide Fragments
  • Proteasome Endopeptidase Complex
  • Protein Structure, Tertiary
  • Receptors, Fc / metabolism
  • T-Lymphocytes, Helper-Inducer / immunology
  • Tumor Cells, Cultured
  • beta-Cyclodextrins*

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 2
  • ATP-Binding Cassette Transporters
  • Cyclodextrins
  • Egg Proteins
  • H-2 Antigens
  • H-2Kb protein, mouse
  • Histocompatibility Antigens Class II
  • Immunosuppressive Agents
  • Membrane Lipids
  • Multienzyme Complexes
  • OVA-8
  • Peptide Fragments
  • Receptors, Fc
  • TAP1 protein, human
  • Tap1 protein, mouse
  • beta-Cyclodextrins
  • methyl-beta-cyclodextrin
  • Ovalbumin
  • Cholesterol
  • Cysteine Endopeptidases
  • Proteasome Endopeptidase Complex